| Geld/Brief | 10,30 € / 10,90 € |
| Spread | +5,83% |
| Schluss Vortag | 10,20 € |
| Gehandelte Stücke | 0 |
| Tagesvolumen Vortag | - |
| Tagestief - Tageshoch - | |
| 52W-Tief - 52W-Hoch 10,20 € | |
| Jahrestief - Jahreshoch 10,20 € | |
| Umsatz in Mio. | - |
| Operatives Ergebnis (EBIT) in Mio. | -59,28 $ |
| Jahresüberschuss in Mio. | -62,55 $ |
| Umsatz je Aktie | - |
| Gewinn je Aktie | -1,28 $ |
| Gewinnrendite | - |
| Umsatzrendite | - |
| Return on Investment | -40,69% |
| Marktkapitalisierung in Mio. | 643,18 $ |
| KGV (Kurs/Gewinn) | - |
| KBV (Kurs/Buchwert) | - |
| KUV (Kurs/Umsatz) | - |
| Eigenkapitalrendite | - |
| Eigenkapitalquote | +85,16% |
| Handelsplatz | Letzter | Änderung | Vortag | Zeit | |
|---|---|---|---|---|---|
| AMEX | 11,99 $ | - | - | 17.09.26 | |
| Düsseldorf | 10,30 € | +3,52% | 9,95 € | 08:13 | |
| Frankfurt | 10,20 € | 0 % | 10,20 € | 18.09.26 | |
| Nasdaq | 12,14 $ | +0,50% | 12,08 $ | 18.09.26 | |
| NYSE | 12,385 $ | +3,51% | 11,965 $ | 18.09.26 | |
| Quotrix | 10,70 € | +1,90% | 10,50 € | 07:27 | |
| Tradegate | 10,00 € | -5,66% | 10,60 € | 16.09.26 | |
| Datum | Kurs | Volumen |
|---|---|---|
| 18.09.26 | 10,20 | 0 |
| 17.09.26 | 9,75 | 0 |
| 16.09.26 | 10,20 | 0 |
| 15.09.26 | 11,00 | 0 |
| 14.09.26 | 11,20 | 0 |
| Zeitraum | Kurs | % |
|---|---|---|
| 1 Woche | 11,80 € | -13,56% |
| 1 Monat | - | - |
| 6 Monate | - | - |
| 1 Jahr | - | - |
| 5 Jahre | - | - |
| Marktkapitalisierung | 643,18 Mio. $ |
| Streubesitz | 45,76% |
| Währung | USD |
| Land | USA |
| Sektor | Gesundheit |
| Branche | Biotechnologie |
| Aktientyp | Stammaktie |
| +10,44% | EQT Fund Management S.à r.l. |
| +5,65% | Sanofi |
| +5,01% | Cormorant Asset Management, LLC |
| +4,17% | TCG Crossover Management, LLC |
| +3,29% | Federated Hermes Inc |
| +3,15% | Casdin Capital, LLC |
| +3,12% | Andera Partners |
| +2,96% | FMR Inc |
| +2,44% | Nantahala Capital Management, LLC |
| +1,99% | Federated Hermes Kaufmann Growth |
| +1,99% | Federated Hermes Kaufmann R |
| +1,44% | Aberdeen Group PLC |
| +1,36% | Fidelity Growth Compy Commingled Pl S |
| +1,25% | Federated Hermes Kaufmann Small Cap Grow |
| +1,25% | Federated Hermes Kaufmann Small Cap A |
| +1,22% | Perceptive Advisors LLC |
| +1,22% | Samsara BioCapital, LLC |
| +1,03% | Fidelity Growth Company Fund |
| +0,84% | Siren, L.L.C. |
| +0,71% | abrdn Healthcare Investors |
| +0,62% | abrdn World Healthcare |
| +0,61% | LMR Partners LLP |
| +0,41% | SEVEN GRAND MANAGERS, LLC |
| +0,35% | abrdn Life Sciences Investors |
| +0,32% | Redmile Group, LLC |
| +0,29% | Fidelity Growth Company K6 |
| +0,26% | Fidelity Series Growth Company |
| +0,19% | Millennium Management LLC |
| +0,18% | Biotech Growth Ord |
| +0,15% | Pfizer Inc |
| +0,15% | Alyeska Investment Group, L.P. |
| +0,1% | ALPS Medical Breakthroughs ETF |
| +0,1% | ALPS Advisors Inc |
| +0,1% | LAURION CAPITAL MANAGEMENT LP |
| +0,1% | Bellevue Group AG |
| +0,08% | Protea Sectoral Hlthcare Opps P USD Acc |
| +0,04% | Federated Hermes Kaufmann II P |
| +0,03% | Protea Sectoral Biotech Opps IF USD Acc |
| +0,02% | Fidelity Nasdaq Composite Index |
| +0,02% | Fidelity Select Pharmaceuticals Port |
| +0,01% | Steward Values Enhanced International I |
| - % | Bellevue Diversified Healthcare U2 CHF |
| +48,349% | Institutionelle Aktionäre |
| +5,895% | Insider Aktionäre |
| +45,756% | Streubesitz |
